OrganiGram Other Stockholder Equity vs Common Stock Shares Outstanding Analysis
OGI Stock | USD 1.76 0.04 2.22% |
OrganiGram Holdings financial indicator trend analysis is much more than just breaking down OrganiGram Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether OrganiGram Holdings is a good investment. Please check the relationship between OrganiGram Holdings Other Stockholder Equity and its Common Stock Shares Outstanding accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.
Other Stockholder Equity vs Common Stock Shares Outstanding
Other Stockholder Equity vs Common Stock Shares Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of OrganiGram Holdings Other Stockholder Equity account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have almost identical trend.
The correlation between OrganiGram Holdings' Other Stockholder Equity and Common Stock Shares Outstanding is 0.95. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of OrganiGram Holdings, assuming nothing else is changed. The correlation between historical values of OrganiGram Holdings' Other Stockholder Equity and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of OrganiGram Holdings are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Other Stockholder Equity i.e., OrganiGram Holdings' Other Stockholder Equity and Common Stock Shares Outstanding go up and down completely randomly.
Correlation Coefficient | 0.95 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Other Stockholder Equity
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most indicators from OrganiGram Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into OrganiGram Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.The OrganiGram Holdings' current Selling General Administrative is estimated to increase to about 59.1 M, while Discontinued Operations is projected to decrease to (35.9 K).
2023 | 2024 (projected) | Reconciled Depreciation | 28.6M | 16.1M | Interest Income | 11.8M | 12.4M |
OrganiGram Holdings fundamental ratios Correlations
Click cells to compare fundamentals
OrganiGram Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
OrganiGram Holdings fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 417.6M | 554.0M | 577.1M | 298.5M | 343.2M | 251.2M | |
Other Current Liab | (11.6M) | 2.8M | 11.0M | 1.2M | 1.4M | 1.6M | |
Total Current Liabilities | 29.1M | 26.3M | 55.3M | 22.4M | 25.8M | 18.3M | |
Total Stockholder Equity | 299.5M | 479.8M | 508.1M | 271.6M | 312.4M | 202.3M | |
Net Debt | 79.1M | (50.4M) | (65.2M) | (29.1M) | (26.2M) | (24.9M) | |
Retained Earnings | (144.9M) | (275.6M) | (289.9M) | (538.5M) | (484.7M) | (460.4M) | |
Cash | 24.6M | 55.4M | 68.5M | 33.9M | 38.9M | 27.4M | |
Non Current Assets Total | 247.4M | 293.4M | 355.5M | 142.5M | 163.9M | 144.2M | |
Non Currrent Assets Other | 8.0M | 31.1M | 32.4M | 613K | 705.0K | 669.7K | |
Cash And Short Term Investments | 74.7M | 183.8M | 98.9M | 33.9M | 38.9M | 58.5M | |
Net Receivables | 17.0M | 21.0M | 46.1M | 30.2M | 34.7M | 36.4M | |
Common Stock Shares Outstanding | 43.2M | 64.0M | 77.2M | 81.3M | 93.5M | 98.2M | |
Liabilities And Stockholders Equity | 417.6M | 554.0M | 577.1M | 298.5M | 343.2M | 251.2M | |
Other Stockholder Equity | 23.7M | 24.7M | 28.3M | 33.2M | 38.2M | 40.1M | |
Total Liab | 118.1M | 74.2M | 69.0M | 26.8M | 30.9M | 48.9M | |
Total Current Assets | 170.2M | 260.6M | 221.6M | 156.0M | 179.4M | 119.0M | |
Property Plant And Equipment Net | 247.4M | 235.9M | 259.8M | 99.0M | 113.9M | 135.1M | |
Accounts Payable | 29.1M | 23.4M | 40.9M | 20.0M | 23.0M | 17.5M | |
Non Current Liabilities Total | 89.0M | 47.9M | 13.8M | 4.4M | 5.1M | 4.8M | |
Accumulated Other Comprehensive Income | 23.8M | 24.6M | 28.3M | 33.2M | 38.2M | 40.1M | |
Common Stock | 420.7M | 730.8M | 769.7M | 776.9M | 893.4M | 938.1M | |
Short Long Term Debt Total | 103.7M | 5.0M | 3.4M | 4.7M | 4.2M | 4.0M | |
Other Liab | 231K | 43.1M | 11.4M | 771K | 886.7K | 842.3K | |
Net Tangible Assets | 297.8M | 462.8M | 451.8M | 261.0M | 300.1M | 258.4M | |
Other Assets | 8.7M | 35.4M | 33.1M | 1.0 | 1.15 | 1.09 | |
Long Term Debt | 46.1M | 103.7M | 230K | 155K | 178.3K | 169.3K | |
Short Term Investments | 380K | 50.1M | 128.5M | 30.4M | 35.0M | 46.6M | |
Inventory | 71.8M | 48.8M | 68.3M | 81.0M | 93.1M | 56.5M | |
Other Current Assets | 23.7M | 7.0M | 8.4M | 11.0M | 12.7M | 11.5M | |
Deferred Long Term Liab | 698K | 7K | 30K | 391K | 449.7K | 354.3K | |
Long Term Investments | 11.1M | 7.0M | 6.1M | 7.1M | 8.1M | 4.3M | |
Short Long Term Debt | 421K | 3.5M | 11.6M | 80K | 92K | 87.4K | |
Short Term Debt | 11.6M | 80K | 996K | 1.1M | 1.3M | 2.3M | |
Intangible Assets | 1.8M | 2.7M | 14.3M | 10.6M | 12.2M | 12.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.Note that the OrganiGram Holdings information on this page should be used as a complementary analysis to other OrganiGram Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for OrganiGram Stock analysis
When running OrganiGram Holdings' price analysis, check to measure OrganiGram Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OrganiGram Holdings is operating at the current time. Most of OrganiGram Holdings' value examination focuses on studying past and present price action to predict the probability of OrganiGram Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OrganiGram Holdings' price. Additionally, you may evaluate how the addition of OrganiGram Holdings to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is OrganiGram Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.83) | Revenue Per Share 1.835 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.55) |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.